Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
International Journal of Cancer|June 13, 2009
Caveolin-1 tumor-promoting role in human melanomaFederica Felicetti, Isabella Parolini, Lisabianca Bottero, et al.Cancer Research|April 18, 2008
The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanismsFederica Felicetti, M Cristina Errico, Lisabianca Bottero, et al.Pigment Cell & Melanoma Research|June 30, 2011
Constitutive activation of the ETS-1-miR-222 circuitry in metastatic melanomaGianfranco Mattia, M Cristina Errico, Federica Felicetti, et al.Regenerative Medicine Research|December 6, 2017
Effect of miR-204&211 and RUNX2 control on the fate of human mesenchymal stromal cellsBenedetto Sacchetti, Alessandro Fatica, Melissa Sorci, et al.Molecular Oncology|May 23, 2019
Joint action of miR-126 and MAPK/PI3K inhibitors against metastatic melanomaFrancesca Pedini, Gabriele De Luca, Federica Felicetti, et al.International Journal of Cancer|February 13, 2013
The abrogation of the HOXB7/PBX2 complex induces apoptosis in melanoma through the miR-221&222-c-FOS pathwayM Cristina Errico, Federica Felicetti, Lisabianca Bottero, et al.Plos One|February 26, 2013
miR-126&126* restored expressions play a tumor suppressor role by directly regulating ADAM9 and MMP7 in melanomaNadia Felli, Federica Felicetti, Anna Maria Lustri, et al.Journal of Experimental & Clinical Cancer Research : CR|October 7, 2018
Acidic microenvironment plays a key role in human melanoma progression through a sustained exosome mediated transfer of clinically relevant metastatic moleculesZaira Boussadia, Jessica Lamberti, Fabrizio Mattei, et al.The Journal of Pathology|March 25, 2015
SCD5-induced oleic acid production reduces melanoma malignancy by intracellular retention of SPARC and cathepsin BMaria Bellenghi, Rossella Puglisi, Francesca Pedini, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|November 22, 2023
MiR126-targeted-nanoparticles combined with PI3K/AKT inhibitor as a new strategy to overcome melanoma resistanceMaria Beatrice Arasi, Gabriele De Luca, Laura Chronopoulou, et al.Pageof 4